ELAN — Elanco Animal Health Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapNeutral

Annual income statement for Elanco Animal Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	R2020 December 31st	R2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	3,071	3,271	4,764	4,411	4,417
Cost of Revenue
Gross Profit	1,601	1,604	2,632	2,498	2,486
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	2,887	3,980	5,094	4,210	5,260
Operating Profit	185	-709	-330	201	-843
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	78.2	-677	-571	-72	-1,195
Provision for Income Taxes
Net Income After Taxes	67.9	-574	-483	-78	-1,231
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	67.9	-574	-483	-78	-1,231
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	67.9	-574	-483	-78	-1,231
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.618	-0.383	-0.146	0.084	-0.957